Therefore, to elucidate the mechanism involved in the loss of SDHB immunoexpression in hemangioblastoma, further comprehensive molecular genetic analyses of SDHx mutations, including promoter methylation and/or VHL testing, should be performed. Here, VHL is linked to hemangioblastoma.